Working… Menu
Trial record 1 of 1 for:    arena pharmaceuticals | PBC
Previous Study | Return to List | Next Study

Safety, Tolerability, and Efficacy of Etrasimod (APD334) in Patients With Primary Biliary Cholangitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03155932
Recruitment Status : Terminated (Sponsor decision.)
First Posted : May 16, 2017
Last Update Posted : February 7, 2020
Information provided by (Responsible Party):
Arena Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : January 31, 2019
Actual Study Completion Date : January 31, 2019
Certification/Extension First Submitted : January 30, 2020